OLMA: Olema Pharmaceuticals, Inc.
Performance
OLMA -11.86%
Watchlist
Select an item
Summary
OLMA at a glance
OLMA returned -11.86% over the past year and -23.33% a year over five years. Its worst drop in that year was -82.11%, smaller than 1% of stocks on Redstone, and its Sharpe ratio of 0.39 beats 45% of stocks on Redstone. It pays no dividends.
Current Drawdown
-79.46%
Rolling Volatility
81.57%
Actions
Metrics
Risk Indicators
Alpha52.95%
Beta0.71x
Sharpe0.39
Sortino1.12
Omega1.14
Calmar-0.14
Martin1.04
Profile
About OLMA
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $644M
- Listed
- Nov 2020
- Employees
- 150
- Headquarters
- San Francisco, CA
- Website
- olema.com
Comparisons